Angeles Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Angeles Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,820	Closed	-$275K	–	82
2024 Q4	$275K	Hold	1,820	–	–	0.01%	149
2024 Q3	$283K	Hold	1,820	–	–	0.01%	171
2024 Q2	$249K	Hold	1,820	–	–	0.01%	177
2024 Q1	$242K	Hold	1,820	–	–	0.01%	190
2023 Q4	$251K	Hold	1,820	–	–	0.02%	168
2023 Q3	$222K	Hold	1,820	–	–	0.02%	161
2023 Q2	$256K	Hold	1,820	–	–	0.02%	129
2023 Q1	$257K	Hold	1,820	–	–	0.02%	121
2022 Q4	$285K	Buy	+1,820	New	+$262K	0.02%	89
2022 Q3	–	Sell	-1,820	Closed	-$242K	–	68
2022 Q2	$242K	Sell	1,820 -430	-19%	-$58.6K	0.02%	91
2022 Q1	$308K	Sell	2,250 -17	-0.7%	-$2.37K	0.02%	85
2021 Q4	$392K	Buy	2,267 +17	+0.8%	+$2.59K	0.02%	143
2021 Q3	$327K	Buy	+2,250	New	+$329K	0.02%	155

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Angeles Investment Advisors's DGX Position: Q1 2025 in Review

Angeles Investment Advisors sold out of Quest Diagnostics (DGX) in Q1 2025, closing a stake of 1,820 shares — an estimated $275K sold.

Angeles Investment Advisors first reported a position in DGX in Q3 2021 and held it in 13 quarters. The position peaked at $392K in Q4 2021. 967 funds tracked by Wall St. Rank hold DGX as of Q1 2025.

Angeles Investment Advisors reported no remaining Quest Diagnostics position as of Q1 2025 after selling out during the quarter.
Angeles Investment Advisors sold 1,820 Quest Diagnostics shares in Q1 2025, an estimated $275K.
Angeles Investment Advisors first reported a position in Quest Diagnostics in Q3 2021 and held it in 13 quarters.
Angeles Investment Advisors's Quest Diagnostics position peaked at $392K in Q4 2021.
967 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2025.

Based on Angeles Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.